Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: A retrospective chart review

Pharmacopsychiatry

Volumn 42, Issue 4, 2009, Pages 153-157

  Bachmann, C J ^a,b   Lehr, D ^c   Theisen, F M ^a,d   Preiss M ^a,e  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Herz Jesu Krankenhaus Fulda   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; FLUPENTIXOL; FLUVOXAMINE; HALOPERIDOL; PIRENZEPINE; PROMETHAZINE; PROTHIPENDYL; SERTRALINE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DROWSINESS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GROUPS BY AGE; HUMAN; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT DURATION; TREATMENT WITHDRAWAL; WEIGHT GAIN; ARTICLE; DRUG COMBINATION; ONSET AGE; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70249147303     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1202266     Document Type: Review

References (27)

1. Abu-Tair F, Kopitz J, Bergemann N. Clozapine augmented with aripiprazole in 5 patients with schizophrenia. J Clin Psychopharmacol 2006; 26 : 669-671
2. Anil Ya?cio?lu AE, Kivircik Akdede BB, Turgut TI et al. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. J Clin Psychiatry 2005; 66 : 63-72
3. Assion HJ, Reinbold H, Lemanski S et al. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial. Pharmacopsychiatry 2008; 41 : 24-28
4. Chang JS, Ahn YM, Park HJ et al. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2008; 69 : 720-731
5. Davies MA, Sheffler DJ, Roth BL. Aripiprazole. A novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev 2004; 10 : 317-336
6. Englisch S, Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32 : 1386-1392
7. Freudenreich O, Henderson DC, Walsh JP et al. Risperidone augmentation for schizophrenia partially responsive to clozapine: a doubleblind, placebo-controlled trial. Schizophr Res 2007; 92 : 90-94
8. Genç Y, Taner E, Candansayar S. Comparison of clozapine- amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. Adv Ther 2007; 24 : 1-13
9. Gibson AP, Lynn Crismon M, Mican LM et al. Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation. Int Clin Psychopharmacol 2007; 22 : 101-105
10. Henderson DC, Kunkel L, Nguyen DD et al. An exploratory open-labeltrial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatr Scand 2006; 113 : 142-147
11. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6 : 65-70
12. Honer WG, Thornton AE, Chen EY et al. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med 2006; 354 : 472-482
13. Josiassen RC, Joseph A, Kohegyi E et al. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, doubleblind, placebo-controlled trial. Am J Psychiatry 2005; 162 : 130-136
14. Karunakaran K, Tungaraza TE, Harborne GC. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia? J Psychopharmacol 2007; 21 : 453-456
15. Kreinin A, Novitski D, Weizman A. Amisulpride treatment of clozapineinduced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study. Int Clin Psychopharmacol 2006; 21 : 99-103
16. Mitsonis CI, Dimopoulos NP, Mitropoulos PA et al. Aripiprazole augmentation in the management of residual symptoms in clozapinetreated outpatients with chronic schizophrenia: An open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31 : 373-377
17. Mouaffak F, Tranulis C, Gourevitch R et al. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia . Clin Neuropharmacol 2006; 29 : 28-33
18. Paton C, Whittington C, Barnes TR. Augmentation with a second anti psychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis. J Clin Psychopharmacol 2007; 27 : 198-204
19. Reinstein MJ, Sonnenberg JG, Mohan SC et al. Use of quetiapine to manage patients who experienced adverse effects with clozapine. Clin Drug Investig 2003; 23 : 63-67
20. Remschmidt H, Schulz E, Martin M et a l. Childhood-onset schizophrenia: history of the concept and recent studies. Schizophr Bull 1994; 20 : 727-745
21. Shapiro DA, Renock S, Arrington E et al. Aripiprazole: A novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacol 2003; 28 : 1400-1411
22. Shiloh R, Zemishlany Z, Aizenberg D et al. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A doubleblind, placebo-controlled study. Br J Psychiatry 1997; 171 : 569-573
23. Winans E. Aripiprazole. Am J Health Pharm 2003; 60 : 2437-2445
24. Yoo HK, Choi SH, Park S et al. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders . J Clin Psychiatry 2007; 68 : 1088-1093
25. Ziegenbein M, Wittmann G, Kropp S. Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation. Clin Drug Investig 2006; 26 : 117-124
26. Zink M, Dressing H. Augmentation of clozapine with atypical antipsychotic substances. Curr Psych Rev 2005; 1 : 165-172
27. Zink M, Kuwilsky A, Krumm B et al. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. J Psychopharmacol 2008, [Epub ahead of print]